ALB and lung carcinoma: For example, lactate concentrations can be heavily underestimated without the addition of an HSA-binding competitor and may even lead to the incorrect interpretation of an apparent lower plasma lactate level in healthy controls as compared to lung cancer patients, who typically have a lower HSA concentration.